Rituximab plus bendamustine as front-line treatment in frail elderly (&gt;70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>

Sergio Storti, Michele Spina, Emanuela Anna Pesce, Flavia Salvi, Michele Merli, Alessia Ruffini, Giuseppina Cabras, Annalisa Chiappella, Emanuele Angelucci, Alberto Fabbri, Anna Marina Liberati, Monica Tani, Gerardo Musuraca, Annalia Molinari, Maria Pia Petrilli, Carmela Palladino, Rosanna Ciancia, Andrea Ferrario, Cristiana Gasbarrino, Federico Monaco, Vincenzo Fraticelli, Annalisa De Vellis, Francesco Merli, Stefano Luminari

Open source

DOI
10.3324/haematol.2017.186569
Published
2018-05-10
Container
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2017.186569,
  title = {Rituximab plus bendamustine as front-line treatment in frail elderly (\&gt;70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>},
  author = {Sergio Storti and Michele Spina and Emanuela Anna Pesce and Flavia Salvi and Michele Merli and Alessia Ruffini and Giuseppina Cabras and Annalisa Chiappella and Emanuele Angelucci and Alberto Fabbri and Anna Marina Liberati and Monica Tani and Gerardo Musuraca and Annalia Molinari and Maria Pia Petrilli and Carmela Palladino and Rosanna Ciancia and Andrea Ferrario and Cristiana Gasbarrino and Federico Monaco and Vincenzo Fraticelli and Annalisa De Vellis and Francesco Merli and Stefano Luminari},
  year = {2018},
  journal = {Haematologica},
  doi = {10.3324/haematol.2017.186569},
  url = {https://doi.org/10.3324/haematol.2017.186569}
}

RIS

TY  - JOUR
TI  - Rituximab plus bendamustine as front-line treatment in frail elderly (&gt;70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>
AU  - Sergio Storti
AU  - Michele Spina
AU  - Emanuela Anna Pesce
AU  - Flavia Salvi
AU  - Michele Merli
AU  - Alessia Ruffini
AU  - Giuseppina Cabras
AU  - Annalisa Chiappella
AU  - Emanuele Angelucci
AU  - Alberto Fabbri
AU  - Anna Marina Liberati
AU  - Monica Tani
AU  - Gerardo Musuraca
AU  - Annalia Molinari
AU  - Maria Pia Petrilli
AU  - Carmela Palladino
AU  - Rosanna Ciancia
AU  - Andrea Ferrario
AU  - Cristiana Gasbarrino
AU  - Federico Monaco
AU  - Vincenzo Fraticelli
AU  - Annalisa De Vellis
AU  - Francesco Merli
AU  - Stefano Luminari
PY  - 2018
JO  - Haematologica
DO  - 10.3324/haematol.2017.186569
UR  - https://doi.org/10.3324/haematol.2017.186569
ER  - 

APA

Storti, S., Spina, M., Pesce, E. A., Salvi, F., Merli, M., Ruffini, A., Cabras, G., Chiappella, A., Angelucci, E., Fabbri, A., Liberati, A. M., Tani, M., Musuraca, G., Molinari, A., Petrilli, M. P., Palladino, C., Ciancia, R., Ferrario, A., Gasbarrino, C., Monaco, F., Fraticelli, V., Vellis, A. D., Merli, F., & Luminari, S. (2018). Rituximab plus bendamustine as front-line treatment in frail elderly (&gt;70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>. Haematologica. https://doi.org/10.3324/haematol.2017.186569

Source records